David Newble joins TTP Labtech as new managing director
David Newble has a proven track record of growing life sciences companies and bringing new technologies and products to the market and is therefore well placed to lead continued growth at TTP Labtech. He was previously chief executive officer (CEO) at TAP Biosystems (now part of Sartorius Stedim Biotech Group), a leading provider of automated cell culture and fermentation systems. During David’s time as CEO, TAP developed and launched a range of small scale automated bioreactors, growing its cell culture business four-fold as a result.
Over the last 14 years TTP Labtech has grown from The Technology Partnership’s (TTP’s) consultancy business to become a global leader in the field of life science automation and instrumentation. David’s appointment will enable TTP Labtech to further strengthen its market position by launching more products and expanding into new application areas.
Most read news
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.